❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Radiation Biology ❭ Flow Cytometry Core Facility ❭

Flow cytometry core facility


Click here
to visit our flow cytometry core facility, situated at Trond Stokke's group.
 
Scroll to top

Home Institute for Cancer Research Dept. of Radiation Biology

  • Eirik Malinen's group
  • Asta Juzeniene's group
  • Heidi Lyng's group
  • Randi Syljuåsen's group
  • Pål Kristian Selbo's group
  • Project groups
  • Department publications
  • Flow Cytometry Core Facility
  • Staff

Recent publications

Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK (2025)
Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab
Biomed Pharmacother, 191, 118550 (in press)
DOI 10.1016/j.biopha.2025.118550, PubMed 40946581

Lindland K, Juzeniene A (2025)
Cytotoxicity of 212Pb-labeled anti-PTK7 antibody in 2D adherent and 3D multicellular bladder cancer models
EJNMMI Radiopharm Chem, 10 (1), 58
DOI 10.1186/s41181-025-00382-3, PubMed 40885785

Switlyk MD, Dale E, Tafjord S, Willumsen L, Hole KH, Hompland T (2025)
Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancer
Sci Rep, 15 (1), 31889
DOI 10.1038/s41598-025-17284-8, PubMed 40883428



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)